Apyx Medical Corporation (APYX) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 8 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for APYX is $6.00, representing a +53.8% upside from the current price of $3.9. Price targets range from a low of $6.00 to a high of $6.00.
